Carlos Agustin Villegas-Valverde

Dr. Carlos Agustin Villegas-Valverde

Stem Cells Laboratory, Abu Dhabi Stem Cells Center, Abu Dhabi, Abū Z̧aby, United Arab Emirates
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CVCarlos Agustin Villegas-Valverde
Carlos Agustin Villegas-Valverde
YVYendry Ventura-Carmenate
Yendry Ventura-Carmenate
Background: Flow cytometry–based immunophenotyping is a powerful tool in clinical and translational immunology; however, the interpretation of lymphocyte immunophenotype results remains incomplete, despite extensive methodological standardization. This challenge is particularly evident when phenotypically normal lymphocytes are quantified under non-physiological conditions, where numerical results are often interpreted using implicit and heterogeneous assumptions. Hypothesis: It is hypothesized that harmonization in flow cytometry–based lymphocyte immunophenotyping must extend beyond technical standardization and incorporate explicit, structured frameworks for biological and clinical interpretation for enumeration of phenotypically normal lymphocyte subsets. Implications: Five foundational guidelines are proposed for interpreting lymphocyte immunophenotypic enumeration: the non-equivalence of relative and absolute metrics, context-dependent relevance of immunophenotypic values, compartment-specific determination of meaning, analytical constraints imposed by assay architecture, and the impact of analytical variability on interpretative stability. By articulating principles that are already implicitly applied in expert practice, this framework complements existing technical guidelines and supports a more consistent, context-aware interpretation of lymphocyte immunophenotypes across diverse clinical and biological settings. Conclusion: By explicitly articulating principles that are typically implicit in expert practice, this framework complements existing technical guidelines and bridges the gap between technical and interpretative reproducibility. It provides a coherent structure for context-aware immunophenotypic interpretation and contributes to a shared conceptual language for the study of immunology and its clinical application.